Certain studies previously pointed out that treating pregnant women with antidepressants
may increase risks of congenital anomalies in their children. However, to date, the study …

Background Increasing numbers of reproductive-aged women are using attention-
deficit/hyperactivity disorder (ADHD) medications. Findings from studies exploring the safety …

Abstract Background Repetitive Transcranial Magnetic Stimulation (rTMS) is an efficacious
treatment for major depressive disorder (MDD), however there is limited safety and efficacy …

Human epidemiological and animal-model studies suggest that separate exposure to stress
or serotonin-selective reuptake inhibitor (SSRI) antidepressants during pregnancy increases …

OBJECTIVES: To determine if in utero selective serotonin reuptake inhibitor (SSRI) or
selective serotonin norepinephrine inhibitor (SNRI) exposure is associated with …

Objectives Data linkage of cohort-based data and electronic health records (EHRs) has
been practised in many countries, but in Hong Kong there is still a lack of such research. To …

The antidepressant fluoxetine (FLX), generally the first line of pharmacological treatment in
adolescents and pregnant women with affective disorders, is an emerging endocrine …

Background Women with bipolar disorder (BD) may continue psychotropics during
pregnancy. The association of exposure to antidepressant, antipsychotics, and mood …

In spite of the preliminary evidence suggesting a link between gestational use of
antidepressant and neurodevelopmental disorders in their offspring, the association …

Introduction Studies have used various epidemiological approaches to study associations
between central nervous system (CNS) drug use in pregnancy and CNS outcomes in …